IDEAYA Biosciences (IDYA) Competitors $24.83 +1.20 (+5.08%) Closing price 04:00 PM EasternExtended Trading$24.83 0.00 (0.00%) As of 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IDYA vs. ELAN, RGC, RVMD, GRFS, TGTX, NUVL, RYTM, CRSP, AXSM, and TLXShould you be buying IDEAYA Biosciences stock or one of its competitors? The main competitors of IDEAYA Biosciences include Elanco Animal Health (ELAN), Regencell Bioscience (RGC), Revolution Medicines (RVMD), Grifols (GRFS), TG Therapeutics (TGTX), Nuvalent (NUVL), Rhythm Pharmaceuticals (RYTM), CRISPR Therapeutics (CRSP), Axsome Therapeutics (AXSM), and Telix Pharmaceuticals (TLX). These companies are all part of the "pharmaceutical products" industry. IDEAYA Biosciences vs. Its Competitors Elanco Animal Health Regencell Bioscience Revolution Medicines Grifols TG Therapeutics Nuvalent Rhythm Pharmaceuticals CRISPR Therapeutics Axsome Therapeutics Telix Pharmaceuticals IDEAYA Biosciences (NASDAQ:IDYA) and Elanco Animal Health (NYSE:ELAN) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, valuation, analyst recommendations, media sentiment, profitability and earnings. Does the media prefer IDYA or ELAN? In the previous week, Elanco Animal Health had 7 more articles in the media than IDEAYA Biosciences. MarketBeat recorded 18 mentions for Elanco Animal Health and 11 mentions for IDEAYA Biosciences. Elanco Animal Health's average media sentiment score of 1.00 beat IDEAYA Biosciences' score of 0.47 indicating that Elanco Animal Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IDEAYA Biosciences 1 Very Positive mention(s) 0 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Elanco Animal Health 4 Very Positive mention(s) 4 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals believe in IDYA or ELAN? 98.3% of IDEAYA Biosciences shares are held by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are held by institutional investors. 2.5% of IDEAYA Biosciences shares are held by company insiders. Comparatively, 0.9% of Elanco Animal Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has better earnings & valuation, IDYA or ELAN? Elanco Animal Health has higher revenue and earnings than IDEAYA Biosciences. IDEAYA Biosciences is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIDEAYA Biosciences$7M310.66-$274.48M-$3.59-6.92Elanco Animal Health$4.44B1.64$338M$0.7419.86 Is IDYA or ELAN more profitable? Elanco Animal Health has a net margin of 8.43% compared to IDEAYA Biosciences' net margin of 0.00%. Elanco Animal Health's return on equity of 7.54% beat IDEAYA Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets IDEAYA BiosciencesN/A -29.28% -27.68% Elanco Animal Health 8.43%7.54%3.57% Which has more volatility and risk, IDYA or ELAN? IDEAYA Biosciences has a beta of 0.03, indicating that its share price is 97% less volatile than the S&P 500. Comparatively, Elanco Animal Health has a beta of 1.67, indicating that its share price is 67% more volatile than the S&P 500. Do analysts prefer IDYA or ELAN? IDEAYA Biosciences presently has a consensus target price of $47.55, indicating a potential upside of 91.48%. Elanco Animal Health has a consensus target price of $16.17, indicating a potential upside of 10.01%. Given IDEAYA Biosciences' higher probable upside, research analysts clearly believe IDEAYA Biosciences is more favorable than Elanco Animal Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IDEAYA Biosciences 0 Sell rating(s) 3 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 2.86Elanco Animal Health 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.88 SummaryElanco Animal Health beats IDEAYA Biosciences on 11 of the 16 factors compared between the two stocks. Get IDEAYA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IDYA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IDYA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IDYA vs. The Competition Export to ExcelMetricIDEAYA BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.07B$3.06B$5.70B$9.48BDividend YieldN/A2.37%4.59%3.99%P/E Ratio-6.9220.7327.9019.95Price / Sales310.66321.12442.19102.72Price / CashN/A43.2336.5558.97Price / Book2.038.308.635.90Net Income-$274.48M-$55.19M$3.24B$258.42M7 Day Performance12.40%5.07%3.22%1.94%1 Month Performance14.00%17.61%10.72%12.02%1 Year Performance-41.18%7.03%34.94%20.81% IDEAYA Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IDYAIDEAYA Biosciences4.1923 of 5 stars$24.83+5.1%$47.55+91.5%-44.9%$2.07B$7M-6.9280News CoverageAnalyst ForecastHigh Trading VolumeELANElanco Animal Health3.5435 of 5 stars$14.67-0.8%$16.00+9.1%+13.2%$7.34B$4.44B15.729,000Analyst ForecastAnalyst RevisionRGCRegencell Bioscience0.358 of 5 stars$14.40-0.7%N/AN/A$7.17BN/A0.0010Gap DownRVMDRevolution Medicines4.5858 of 5 stars$38.42+0.3%$68.91+79.4%-19.8%$7.13B$11.58M0.00250Positive NewsGRFSGrifols3.426 of 5 stars$10.00+0.6%$10.30+3.0%+27.1%$6.83B$7.81B8.5523,822Upcoming EarningsTGTXTG Therapeutics3.7211 of 5 stars$37.42-1.3%$43.80+17.0%+85.5%$6.02B$329M157.96290Positive NewsNUVLNuvalent3.3157 of 5 stars$82.46-1.1%$119.60+45.0%-2.5%$5.99BN/A0.0040Analyst ForecastRYTMRhythm Pharmaceuticals3.2498 of 5 stars$88.63-0.6%$91.93+3.7%+76.3%$5.68B$130.13M-31.54140CRSPCRISPR Therapeutics1.7589 of 5 stars$65.33+0.3%$71.75+9.8%+19.1%$5.62B$37.31M-14.45460Analyst ForecastAnalyst RevisionHigh Trading VolumeAXSMAxsome Therapeutics4.7148 of 5 stars$109.68-1.8%$172.33+57.1%+24.2%$5.50B$385.69M-19.01380Analyst RevisionTLXTelix PharmaceuticalsN/A$16.50+1.7%$22.33+35.4%N/A$5.49B$516.72M0.00N/ATrending NewsAnalyst RevisionHigh Trading Volume Related Companies and Tools Related Companies Elanco Animal Health Alternatives Regencell Bioscience Alternatives Revolution Medicines Alternatives Grifols Alternatives TG Therapeutics Alternatives Nuvalent Alternatives Rhythm Pharmaceuticals Alternatives CRISPR Therapeutics Alternatives Axsome Therapeutics Alternatives Telix Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IDYA) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersElon Just Fired the IRS Agents Targeting Your SavingsElon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regai...Priority Gold | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredTrump’s Endgame? (R.I.P. China)Tucked inside a Silicon Valley factory, a bold new tech is quietly emerging—one that could ignite a $12 trilli...Brownstone Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredBitcoin Beats Gold — But This Coin Could Beat Them BothBitcoin just hit a record high—but it’s not the top crypto play right now. Crypto analyst Juan Villaverde, ...Weiss Ratings | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IDEAYA Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IDEAYA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IDYA Stock Alerts